APC/Cyanine7 anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
  • 30-F11_APCCyanine7_CD45_Antibody_013019_updated.png
    C57BL/6 splenocytes were stained with CD45 (clone 30-F11) APC/Cyanine7 (filled histogram) or Rat IgG2b, ? APC/Cyanine7 isotype control (open histogram).
See APC/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
103115 25 µg $85.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103116 100 µg $190.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is = 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6 and Western blotting7. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Additional Product Notes
BioLegend is in the process of converting the name APC/Cy7 to APC/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our APC/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
Product Citations
  1. Haka A, et al. 2012. PLoS One. 7:e44823. PubMed
  2. Khandelwal P, et al. 2013. PLoS One. 8:64193. PubMed
  3. Seeling M, et al. 2013. Proc Natl Acad Sci U S A. 110:10729. PubMed
  4. Shibata K, et al. 2014. J Immunol. 192:2210. PubMed
  5. Lux A, et al. 2014. Cell Rep. 10:236. PubMed
  6. Mantia-Smaldone G, et al. 2014. Gynecol Oncol. 133:584. PubMed
  7. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  8. Abramowski P, et al. 2014. J Neuroimmunol. 274:111. PubMed
  9. Hoeksema M, et al. 2015. J Immunol. 194:3909. PubMed
  10. Seki T, et al. 2015. J Biochem. 158: 485 - 495. PubMed
  11. Gierut J, et al. 2015. Stem Cell Res. 15: 165-171. PubMed
  12. Stock M, et al. 2015. Osteoarthritis Cartilage. 23: 1221-1225. PubMed
  13. Holzapfel B, et al. 2015. Biomaterials. 61: 103-114. PubMed
  14. Veremeyko T, et al. 2012. J Vis Exp. 65: 4097. PubMed
  15. Martina M, et al. 2014. J Vis Exp. 87: 51192. PubMed
  16. Evans H, et al. 2015. J Immunol. 195: 2973 - 2984. PubMed
  17. Cardona S, et al. 2015. ASN Neuro. 7: 1759091415608204. PubMed
  18. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  19. JI B, et al. 2016. Cell Death Differ. 23:759-75. PubMed
  20. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  21. Cordeiro O, et al. 2016. PLoS One. 11: 0151848. PubMed
  22. Martina M, et al. 2016. J Am Soc Nephrol. 27: 1113-1123. PubMed
  23. Madsen P, et al. 2016. J Neurosci. 36: 5128 - 5143. PubMed
  24. Campisi L, et al. 2016. Nat Immunol. 10.1038/ni.3512. PubMed
  25. Klein S, et al. 2016. J Cell Sci. 129: 2573 - 2585. PubMed
  26. Fox B, et al. 2016. PLoS One. 12: 1006189. PubMed
  27. AR P, et al. 2016. Circ Res. 118: 400-409. PubMed
  28. Chew W, et al. 2016. Nat Methods. 13: 868-874. PubMed
  29. Rossnagl S, et al. 2016. PLoS Biol. 14: 1002562. PubMed
  30. Parker K, Horn L, Ostrand-Rosenberg S 2016. J Leukoc Biol. 100: 463 - 470.. PubMed
  31. Yoldi G, et al. 2016. Cancer Res . 76: 5857 - 5869. PubMed
  32. E O’Koren, R Mathew, D Saban 2016. Sci Rep. 6:20636. PubMed
  33. Kokona D, et al. 2016. Exp Eye Res. S0014-4835(16)30499-7. PubMed
  34. Ling Y, et al. 2016. Pharmacol Res. S1043-6618(16)31329-9. PubMed
  35. Liu M, et al. 2020. Cell Rep. 32:107990. PubMed
  36. Dhanwani R, et al. 2020. Sci Adv. 6:eaba3688. PubMed
  37. Ye Y, et al. 2020. Genome Med. 0.557638889. PubMed
  38. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  39. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  40. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  41. Zhang X, et al. 2020. Elife. 9:00. PubMed
  42. Montel-Hagen A, et al. 2020. Cell Rep. 33:108320. PubMed
  43. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  44. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  45. Wang LT, et al. 2020. Cell Rep. 32:108188. PubMed
  46. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  47. Blaszczak AM, et al. 2020. Immunometabolism. 2:00. PubMed
  48. Zelco A, et al. 2020. Front Cell Neurosci. 0.75625. PubMed
  49. Ukidve A, et al. 2020. Proc Natl Acad Sci U S A. 117:17727. PubMed
  50. Dieterich LC, et al. 2020. Angiogenesis. 1.24375. PubMed
  51. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  52. Hirata SI, et al. 2020. Allergy. 75:1939. PubMed
  53. Ou YC, et al. 2020. ACS Nano. 1.035416667. PubMed
  54. Fachi JL, et al. 2020. J Exp Med. 217:00:00. PubMed
  55. Tripathi H, et al. 2020. Stem Cell Rev Rep. 0.953472222. PubMed
  56. Chang YS, et al. 2020. Int J Mol Sci. 21:00. PubMed
  57. Naito H, et al. 2020. Nature Protocols. 15(3):1066-1081. PubMed
  58. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  59. Da Mesquita S, et al. 2021. Science Advances. 7(21):. PubMed
  60. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  61. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  62. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  63. Lu C, et al. 2020. Cancer Cell. 39(1):96-108.e6. PubMed
  64. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  65. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  66. Shannon JP, et al. 2021. Immunity. 54(2):276-290.e5. PubMed
  67. Ma Y, et al. 2021. Developmental Cell. 56(4):478-493.e11. PubMed
  68. Wang LT, et al. 2021. STAR Protocols. 2(1):100337. PubMed
  69. Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
  70. Frii J, et al. 2021. Immunity. 54(5):1002-1021.e10. PubMed
  71. Uzhachenko RV, et al. 2021. Cell Reports. 35(1):108944. PubMed
  72. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  73. Ito Y, et al. 2021. Cell Reports. 35(4):109052. PubMed
  74. Zhu B, et al. 2021. Immunity. 54(6):1200-1218.e9. PubMed
  75. McFarland AP, et al. 2021. Immunity. 54(6):1320-1337.e4. PubMed
  76. Xing J, et al. 2021. Cell Reports. 35(12):109205. PubMed
  77. Marangoni F, et al. 2021. Cell. . PubMed
  78. Ebneter A, et al. 2017. Transl Vis Sci Technol. 10.1167/tvst.6.2.10. PubMed
  79. Ayaub E,et al. 2017. Sci Rep.. 10.1038/s41598-017-13511-z. PubMed
  80. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  81. Wang X, et al. 2018. Nat Commun. 9:551. PubMed
  82. Armaka M, et al. 2018. Nat Commun. 9:618. PubMed
  83. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  84. Lyons J, et al. 2018. PLoS Biol. 16:e2002417. PubMed
  85. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  86. Cignarella F et al. 2018. Cell metabolism. 27(6):1222-1235 . PubMed
  87. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  88. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  89. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  90. Hammond TR, et al. 2019. Immunity. 50:253. PubMed
  91. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  92. Wakabayashi T et al. 2018. Cell stem cell. 22(3):384-397 . PubMed
  93. Veremeyko T, et al. 2019. J Neurosci Res. 97:162. PubMed
  94. Selvaraj UM et al. 2018. Endocrinology. 159(11):3848-3859 . PubMed
  95. Tordesillas L, et al. 2018. Nat Commun. 9:5238. PubMed
  96. Haikala HM, et al. 2019. Nat Commun. 10:620. PubMed
  97. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  98. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  99. Sydney Lavoie et al. 2019. eLife. 8 pii: e39982. PubMed
  100. Contijoch EJ et al. 2019. eLife. 8 pii: e40553. PubMed
  101. Koliaraki V et al. 2019. Cell reports. 26(3):536-545 . PubMed
  102. Commerford CD et al. 2018. Cell reports. . PubMed
  103. Petriello MC, et al. 2018. Toxicol Sci. 162:548. PubMed
  104. Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed
  105. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  106. Kim MY, et al. 2018. Cell. 173:1439. PubMed
  107. Jiang P, et al. 2018. Nat Med. 24:1550. PubMed
  108. Zeng J, et al. 2019. Cell Rep. 27:549. PubMed
  109. Yousef H, et al. 2018. Bio Protoc. 8:22. PubMed
  110. Li Y, et al. 2019. Sci Rep. 9:6932. PubMed
  111. Ajina R, et al. 2019. Oncoimmunology. 8:e1577127. PubMed
  112. Evans R, et al. 2019. Cell Rep. 27:1967. PubMed
  113. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  114. Halpern KB, et al. 2018. Nat Biotechnol. 36:962. PubMed
  115. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  116. Page N, et al. 2018. Immunity. 48:937. PubMed
  117. Haertel E, et al. 2018. Eur J Immunol. 48:1001. PubMed
  118. Lyons J, et al. 2018. Sci Signal. 11. PubMed
  119. Kaiser T, et al. 2019. Eneuro. 6. PubMed
  120. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  121. Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
  122. Xueyang Yu et al. 2017. Immunity. 47(5):903-912 . PubMed
  123. Saleh MM, et al. 2019. Cell Host Microbe. 25:756. PubMed
  124. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  125. Komuczki J, et al. 2019. Immunity. 50:1289. PubMed
  126. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  127. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  128. Ganeshan K et al. 2019. Cell. 177(2):399-413 . PubMed
  129. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  130. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  131. Theurich S et al. 2017. Cell metabolism. 26(1):171-184 . PubMed
  132. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  133. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  134. El Agha E, et al. 2017. Cell Stem Cell. 1.014583333. PubMed
  135. Martin A, et al. 2018. Oncotarget. 9:28364. PubMed
  136. Higashi AY, et al. 2019. J Am Soc Nephrol. 30:80. PubMed
  137. Ning F, et al. 2019. J Exp Med. 216:1396. PubMed
  138. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  139. Weiner AI, et al. 2019. NPJ Regen Med. 4:17. PubMed
  140. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  141. Godwin MS, et al. 2019. JCI Insight. 4:e126070. PubMed
  142. Kashyap AS, et al. 2019. Cell Rep. 28:3367. PubMed
  143. Wiley CD, et al. 2019. JCI Insight. 4:e130056. PubMed
  144. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  145. Pluchino N, et al. 2020. J Cell Mol Med. 24:2464. PubMed
  146. Zhao Y, et al. 2020. Front Immunol. 2.572222222. PubMed
  147. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  148. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  149. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  150. Soldevilla MM, et al. 2019. Mol Ther. 27:1878. PubMed
  151. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  152. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  153. Alikhanyan K, et al. 2020. Immun Inflamm Dis. 8:181. PubMed
  154. Ireland L, et al. 2020. Front Immunol. 11:297. PubMed
  155. Cheng Y, et al. 2019. Clin Cancer Res. 25:2621. PubMed
  156. Han Y, et al. 2020. Nat Commun. 11:1776. PubMed
  157. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  158. Bahar Halpern K, et al. 2020. Nat Commun. 11:1936. PubMed
  159. Ben-Moshe S, et al. 2019. Nat Metab. 1:899. PubMed
  160. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  161. Gago-Lopez N, et al. 2019. EMBO Mol Med. 11:e10697. PubMed
  162. Fransén Pettersson N, et al. 2018. PLoS One. 13:e0203228. PubMed
  163. Forte E, et al. 2020. Cell Rep. 30:3149. PubMed
  164. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  165. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  166. Wang J, et al. 2020. J Hematol Oncol. 0.610416667. PubMed
  167. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  168. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  169. Sztwiertnia I, et al. 2020. PLoS One. 15:e0233789. PubMed
  170. Camara A, et al. 2019. Immunity. 50:1467. PubMed
  171. Liu H, et al. 2020. Cancer Cell. 37(3):324-339. PubMed
  172. Uluçkan ö, et al. 2020. Cell Reports. 29(4):844-859.e3.. PubMed
  173. Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
  174. Chun E, et al. 2020. Immunity. 51(5):871-884.e6.. PubMed
  175. Huang B, et al. 2020. Cell. 179(5):1160-1176.e24.. PubMed
  176. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  177. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  178. Hohsfield LA, et al. 2020. J Neuroinflammation. 0.902083333. PubMed
  179. Willemze RA, et al. 2019. Mol Med. 25:01:00. PubMed
  180. Utz B, et al. 2020. Sci Rep. 10:18733. PubMed
  181. Michaelis KA, et al. 2019. Brain Behav Immun. 82:338. PubMed
  182. Krasteva G, et al. 2011. Proc Natl Acad Sci U S A. 108:9478. PubMed
  183. Draper D, et al. 2012. J Immunol. 188:5327. PubMed
RRID
AB_312980 (BioLegend Cat. No. 103115)
AB_312981 (BioLegend Cat. No. 103116)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD45
Specificity Alt (DOES NOT SHOW ON TDS):
CD45
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 01/30/2019

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Insert Note Here
Save Close Clear
Lab Timer
Tools
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account